Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Open accessAbstract
Enhanced metabotropic glutamate receptor subunit 5 (mGluR5) function is causally associated with the pathophysiology of fragile X syndrome, a leading inherited cause of intellectual disability and autism. Here we provide evidence that altered mGluR5-Homer scaffolds contribute to mGluR5 dysfunction and phenotypes in the fragile X syndrome mouse model, Fmr1 knockout (Fmr1(-/y)). In Fmr1(-/y) mice, mGluR5 was less associated with long Homer isoforms but more associated with the short Homer1a. Genetic deletion of Homer1a restored mGluR5-long Homer scaffolds and corrected several phenotypes in Fmr1(-/y) mice, including altered mGluR5 signaling, neocortical circuit dysfunction and behavior. Acute, peptide-mediated disruption of mGluR5-Homer scaffolds in wild-type mice mimicked many Fmr1(-/y) phenotypes. In contrast, Homer1a deletion did not rescue altered mGluR-dependent long-term synaptic depression or translational control of target mRNAs of fragile X mental retardation protein, the gene product of Fmr1. Our findings reveal new functions for mGluR5-Homer interactions in the brain and delineate distinct mechanisms of mGluR5 dysfunction in a mouse model of cognitive dysfunction and autism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Enhanced mTOR signaling and cap-dependent translation initiation complex are found also in mouse models of human Fragile X Syndrome, characterized by the lack of FMRP.
“Enhanced mTOR signaling and cap-dependent translation initiation complex are found also in mouse models of human Fragile X Syndrome, characterized by the lack of FMRP.85, 86, 87”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S. K., Kim, J., Kouser, M., Schwartz, J. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 115 · see citing works
Self-citationRetractedModel of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · see citing works
Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology
Uhlhaas, P. J., & Singer, W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.020 · Cited by 2,194 · see citing works
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · see citing works
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · see citing works
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works
Self-citationCellular and network mechanisms of rhythmic recurrent activity in neocortex
Sanchez-Vives, M. V., & McCormick, D. A. (2000) · Nature Neuroscience · doi:10.1038/79848 · Cited by 1,539 · see citing works
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,075 · see citing works
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051 · see citing works
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · see citing works
Self-citationTranslational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory
Kelleher, R. J., Govindarajan, A., Jung, H.-Y., Kang, H., & Tonegawa, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00115-1 · Cited by 845 · see citing works
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · see citing works
Xiao, B., Tu, J. C., Petralia, R. S., Yuan, J. P., Doan, A., Breder, C. D., Ruggiero, A. M., Lanahan, A. A., Wenthold, R. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80588-7 · Cited by 649 · see citing works
Self-citationLüscher, C., & Huber, K. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.016 · Cited by 627 · see citing works
Self-citationJacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., Ramos, F. J., Cornish, K., He, Y., Paulding, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001708 · Cited by 609 · see citing works
(1994) · PubMed · Cited by 565 · see citing works
Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation
Billuart, P., Bienvenu, T., Ronce, N., Portes, V. D., Vinet, M. C., Zemni, R., Crollius, H. R., Carrié, A., Fauchereau, F., Chery, M., et al. (1998) · Nature · doi:10.1038/31940 · Cited by 560 · see citing works
Dysregulation of mTOR signaling in fragile X syndrome
Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557 · see citing works
Gibson, J. R., Bartley, A. F., Hays, S. A., & Huber, K. M. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90752.2008 · Cited by 529 · see citing works
Self-citationSignalling to translation: How signal transduction pathways control the protein synthetic machinery
Proud, C. G. (2007) · Biochemical Journal · doi:10.1042/bj20070024 · Cited by 520 · see citing works
Park, S., Park, J. M., Kim, S., Kim, J.-A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A. G., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.023 · Cited by 516 · see citing works
Self-citationWaung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474 · see citing works
Self-citationRapid Neocortical Dynamics: Cellular and Network Mechanisms
Haider, B., & McCormick, D. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.008 · Cited by 441 · see citing works
Ango, F., Prézeau, L., Müller, T. H., Tu, J. C., Xiao, B., Worley, P. F., Pin, J., Bockaert, J., & Fagni, L. (2001) · Nature · doi:10.1038/35082096 · Cited by 410 · see citing works
Self-citationOsterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · see citing works
NMDA receptor-mediated control of protein synthesis at developing synapses
Scheetz, A., Nairn, A., & Constantine-Paton, M. (2000) · Nature Neuroscience · doi:10.1038/72915 · Cited by 382 · see citing works
Muddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364 · see citing works
Shiraishi‐Yamaguchi, Y., & Furuichi, T. (2007) · Genome biology · doi:10.1186/gb-2007-8-2-206 · Cited by 324 · see citing works
Epilepsy in fragile X syndrome
Berry‐Kravis, E. (2002) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2002.tb00277.x · Cited by 271 · see citing works
Homeostatic Scaling Requires Group I mGluR Activation Mediated by Homer1a
Hu, J.-H., Park, J. M., Park, S. J., Xiao, B., Dehoff, M. H., Kim, S., Hayashi, T., Schwarz, M. K., Huganir, R. L., Seeburg, P. H., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.008 · Cited by 263 · see citing works
Self-citationFragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack
Brown, M. R., Kronengold, J., Gazula, V., Chen, Y., Strumbos, J. G., Sigworth, F. J., Navaratnam, D. S., & Kaczmarek, L. K. (2010) · Nature Neuroscience · doi:10.1038/nn.2563 · Cited by 261 · see citing works
Mao, L., Yang, L., Tang, Q., Samdani, S., Zhang, G., & Wang, J. Q. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4360-04.2005 · Cited by 250 · see citing works
Banko, J. L., Hou, L., Poulin, F., Sonenberg, N., & Klann, E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5196-05.2006 · Cited by 245 · see citing works
Ronesi, J. A., & Huber, K. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5019-07.2008 · Cited by 244 · see citing works
Self-citationGross, C., Nakamoto, M., Yao, X., Chan, C.-B., Yim, S. Y., Ye, K., Warren, S. T., & Bassell, G. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0402-10.2010 · Cited by 241 · see citing works
Herbert, T. P., Tee, A. R., & Proud, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110367200 · Cited by 181 · see citing works
Protein translation in synaptic plasticity: mGluR-LTD, Fragile X
Waung, M. W., & Huber, K. M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.03.011 · Cited by 174 · see citing works
Self-citationHays, S. A., Huber, K. M., & Gibson, J. R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3157-11.2011 · Cited by 167 · see citing works
Self-citationMechanism-based approaches to treating fragile X
Dölen, G., Carpenter, R. L., Ocain, T. D., & Bear, M. F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.008 · Cited by 124 · see citing works
Giuffrida, R., Musumeci, S., D'Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B. A., & Catania, M. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0932-05.2005 · Cited by 119 · see citing works
NFAT Binding and Regulation of T Cell Activation by the Cytoplasmic Scaffolding Homer Proteins
Huang, G. N., Huso, D. L., Bouyain, S., Tu, J., McCorkell, K. A., May, M. J., Zhu, Y., Lutz, M. A., Collins, S. L., Dehoff, M. H., et al. (2008) · Science · doi:10.1126/science.1151227 · Cited by 113 · see citing works
Self-citationDissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome.
Liu, Z.-H., & Smith, C. B. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.066 · Cited by 112 · see citing works
Ronesi, J. A., & Huber, K. M. (2008) · Science Signaling · doi:10.1126/stke.15pe6 · Cited by 106 · see citing works
Self-citationThomas, A. M., Bui, N., Perkins, J. R., Yuva‐Paylor, L. A., & Paylor, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2375-4 · Cited by 99 · see citing works
Thomas, A. M., Bui, N., Graham, D. F., Perkins, J. R., Yuva‐Paylor, L. A., & Paylor, R. E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.049 · Cited by 74 · see citing works
Kindling‐induced overexpression of Homer 1A and its functional implications for epileptogenesis
Potschka, H., Krupp, E., Ebert, U., Gümbel, C., Leichtlein, C. B., Lorch, B., Pickert, A., Kramps, S., Young, K., Grüne, U., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02265.x · Cited by 68 · see citing works
Self-citationMizutani, A., Kuroda, Y., Futatsugi, A., Furuichi, T., & Mikoshiba, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4738-07.2008 · Cited by 65 · see citing works
Analysis of the QTL for sleep homeostasis in mice:Homer1ais a likely candidate
Mackiewicz, M., Paigen, B. J., Naidoo, N. N., & Pack, A. I. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00189.2007 · Cited by 59 · see citing works
Orlando, L. R., Ayala, R., Kett, L. R., Curley, A. A., Duffner, J. L., Bragg, D. C., Tsai, L., Dunah, A. W., & Young, A. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06139.x · Cited by 45 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [4]Hagerman R Hagerman R Hagerman P The physical and behavioral phenotype Fragile X Syndrome: Diagnosis, Treatment, and Research 2002 3 109 The Johns Hopkins University Press Baltimore
Cited by
Sorted by citations
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797 · see citing works
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572 · see citing works
The translation of translational control by FMRP: therapeutic targets for FXS
Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491 · see citing works
Altered Neuronal and Circuit Excitability in Fragile X Syndrome
Contractor, A., Klyachko, V. A., & Portera‐Cailliau, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.017 · Cited by 425 · see citing works
Exaggerated translation causes synaptic and behavioural aberrations associated with autism
Santini, E., Huynh, T. N., MacAskill, A. F., Carter, A. G., Pierre, P., Ruggero, D., Kaphzan, H., & Klann, E. (2012) · Nature · doi:10.1038/nature11782 · Cited by 376 · see citing works
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326 · see citing works
The WAVE regulatory complex links diverse receptors to the actin cytoskeleton
Chen, B., Brinkmann, K., Chen, Z., Pak, C. W., Liao, Y., Shi, S., Henry, L., Grishin, N. V., Bogdan, S., & Rosen, M. K. (2014) · Cell · doi:10.1016/j.cell.2013.11.048 · Cited by 323 · see citing works
Wang, X., Bey, A. L., Katz, B. M., Badea, A., Kim, N., David, L. K., Duffney, L. J., Kumar, S., Mague, S. D., Hulbert, S. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms11459 · Cited by 318 · see citing works
Dysregulation and restoration of translational homeostasis in fragile X syndrome
Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275 · see citing works
Synaptopathology Involved in Autism Spectrum Disorder
Guang, S., Pang, N., Deng, X., Yang, L., He, F. P., Wu, L., Chen, C., Yin, F., & Peng, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00470 · Cited by 283 · see citing works
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
Jung, K., Sepers, M. D., Henstridge, C. M., Lassalle, O., Neuhofer, D. N., Martin, H. G. S., Ginger, M. R., Frick, A., DiPatrizio, N. V., Mackie, K., et al. (2012) · Nature Communications · doi:10.1038/ncomms2045 · Cited by 282 · see citing works
Organization and functions of mGlu and GABAB receptor complexes
Pin, J., & Bettler, B. (2016) · Nature · doi:10.1038/nature20566 · Cited by 274 · see citing works
HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory
Sando, R., Gounko, N., Pieraut, S., Liao, L., Yates, J., & Maximov, A. (2012) · Cell · doi:10.1016/j.cell.2012.09.037 · Cited by 274 · see citing works
Homeostatic Control of Presynaptic Neurotransmitter Release
Davis, G. W., & Müller, M. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071740 · Cited by 261 · see citing works
Homeostatic Signaling and the Stabilization of Neural Function
Davis, G. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.044 · Cited by 271 · see citing works
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Eissa, N., Al‐Houqani, M., Sadeq, A. S., Ojha, S. K., Sasse, A., & Sadek, B. S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00304 · Cited by 263 · see citing works
Uzunova, G., Pallanti, S., & Hollander, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1085597 · Cited by 242 · see citing works
Lombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.15 · Cited by 201 · see citing works
Astrocytes and Microglia and Their Potential Link with Autism Spectrum Disorders
Petrelli, F., Pucci, L., & Bezzi, P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00021 · Cited by 186 · see citing works
Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167 · see citing works
Self-citationGenetics of glutamate and its receptors in autism spectrum disorder
Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 173 · see citing works
Oh, W. C., Hill, T. C., & Zito, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214705110 · Cited by 163 · see citing works
Sidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155 · see citing works
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
Vicidomini, C., Ponzoni, L., Lim, D., Schmeißer, M. J., Reim, D., Morello, N., Orellana, D. I., Tozzi, A., Durante, V., Scalmani, P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.30 · Cited by 141 · see citing works
Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment
Trujillo, C. A., Rice, E. S., Schaefer, N. K., Chaim, I. A., Wheeler, E. C., Madrigal, A. A., Buchanan, J., Preißl, S., Wang, A., Negraes, P. D., et al. (2021) · Science · doi:10.1126/science.aax2537 · Cited by 146 · see citing works
Genetic aspects of autism spectrum disorders: insights from animal models
Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 137 · see citing works
Qiao, H., An, S.-C., Xu, C. S., & Ma, X. (2017) · Brain Research · doi:10.1016/j.brainres.2017.02.020 · Cited by 137 · see citing works
Synaptic retinoic acid signaling and homeostatic synaptic plasticity
Chen, L., Lau, A. G., & Sarti, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.004 · Cited by 128 · see citing works
de Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 126 · see citing works
Decker, J., Krüger, L., Sydow, A., Dennissen, F. J., Šišková, Z., Mandelkow, E., & Mandelkow, E. (2016) · EMBO Reports · doi:10.15252/embr.201541439 · Cited by 115 · see citing works
Channelopathy pathogenesis in autism spectrum disorders
Schmunk, G., & Gargus, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00222 · Cited by 118 · see citing works
Gross, C., Chang, C.-W., Kelly, S. M., Bhattacharya, A., McBride, S. M. J., Danielson, S. W., Jiang, M. Q., Chan, C. B., Ye, K., Gibson, J. R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.060 · Cited by 117 · see citing works
Self-citationOf Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works
Genetic and non-genetic animal models for autism spectrum disorders (ASD)
Ergaz, Z., Weinstein‐Fudim, L., & Ornoy, A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.04.024 · Cited by 116 · see citing works
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118 · see citing works
Kelleher III, R. J., Geigenmüller, U., Hovhannisyan, H., Trautman, E., Pinard, R., Rathmell, B., Carpenter, R., & Margulies, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035003 · Cited by 116 · see citing works
Tuning Specific Translation in Cancer Metastasis and Synaptic Memory: Control at the MNK–eIF4E Axis
Bramham, C. R., Jensen, K. B., & Proud, C. G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.07.008 · Cited by 106 · see citing works
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105 · see citing works
Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
Montanari, M., Martella, G., Bonsi, P., & Meringolo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073861 · Cited by 105 · see citing works
Channelopathies in fragile X syndrome
Deng, P., & Klyachko, V. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00445-9 · Cited by 105 · see citing works
Aloisi, E., Corf, K. L., Dupuis, J. P., Zhang, P., Ginger, M. R., Labrousse, V. F., Spatuzza, M., Haberl, M. G., Costa, L., Shigemoto, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01191-2 · Cited by 98 · see citing works
Astrocyte Glutamate Uptake and Signaling as Novel Targets for Antiepileptogenic Therapy
Peterson, A. R., & Binder, D. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01006 · Cited by 104 · see citing works
Meechan, D. W., Maynard, T. M., Tucker, E. S., Fernandez, A., Karpinski, B. A., Rothblat, L. A., & LaMantia, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.004 · Cited by 97 · see citing works
Menna, L. D., Joffe, M. E., Iacovelli, L., Orlando, R., Lindsley, C. W., Mairesse, J., Gressèns, P., Cannella, M., Caraci, F., Copani, A., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.026 · Cited by 97 · see citing works
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.003 · Cited by 94 · see citing works
Self-citationSantini, E., Huynh, T. N., Longo, F., Koo, S. Y., Mojica, E. S., D’Andrea, L., Bagni, C., & Klann, E. (2017) · Science Signaling · doi:10.1126/scisignal.aan0665 · Cited by 91 · see citing works
Ménard, C., & Quirion, R. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00182 · Cited by 88 · see citing works
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 91 · see citing works
Metabotropic glutamate receptors as drug targets: what's new?
Nicoletti, F., Bruno, V., Ngomba, R. T., Gradini, R., & Battaglia, G. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.002 · Cited by 90 · see citing works
Scaffold protein Homer 1: Implications for neurological diseases
Luo, P., Li, X., Fei, Z., & Poon, W. S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.014 · Cited by 87 · see citing works
Santos, A. R., Kanellopoulos, A. K., & Bagni, C. (2014) · Learning & Memory · doi:10.1101/lm.035956.114 · Cited by 86 · see citing works
Regulation and Function of Activity-Dependent Homer in Synaptic Plasticity
Clifton, N. E., Trent, S., Thomas, K. L., & Hall, J. (2019) · Complex Psychiatry · doi:10.1159/000500267 · Cited by 85 · see citing works
Ade, K. K., Wan, Y., Hamann, H. C., O’Hare, J. K., Guo, W., Quian, A., Kumar, S., Bhagat, S., Rodriguiz, R. M., Wetsel, W. C., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.023 · Cited by 84 · see citing works
Self-citationCannabis and Endocannabinoid Signaling in Epilepsy
Katona, I. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_10 · Cited by 81 · see citing works
Holz, A., Mülsch, F., Schwarz, M. K., Hollmann, M., Döbrössy, M. D., Coenen, V. A., Bartos, M., Normann, C., Biber, K. P. H., van Calker, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.011 · Cited by 79 · see citing works
Pignatelli, M., Piccinin, S., Molinaro, G., Menna, L. D., Riozzi, B., Cannella, M., Motolese, M., Vetere, G., Catania, M. V., Battaglia, G., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1846-13.2014 · Cited by 77 · see citing works
Synapse development organized by neuronal activity-regulated immediate-early genes
Kim, S., Kim, H., & Um, J. W. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0025-1 · Cited by 77 · see citing works
Translational Concepts of mGluR5 in Synaptic Diseases of the Brain
Piers, T. M., Kim, D. H., Kim, B. C., Regan, P. L., Whitcomb, D. J., & Cho, K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00199 · Cited by 76 · see citing works
Gross, C., Raj, N., Molinaro, G., Allen, A. G., Whyte, A. J., Gibson, J. R., Huber, K. M., Gourley, S. L., & Bassell, G. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.065 · Cited by 71 · see citing works
Self-citationNoncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-021821-091747 · Cited by 71 · see citing works
Bennett, K. A., Tehan, B. G., Lebon, G., Tate, C. G., Weir, M., Marshall, F. H., & Langmead, C. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084509 · Cited by 73 · see citing works
de Bartolomeis, A., Sarappa, C., Buonaguro, E. F., Marmo, F., Eramo, A., Tomasetti, C., & Iasevoli, F. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.010 · Cited by 72 · see citing works
Shank mutant mice as an animal model of autism
Yoo, J., Bakes, J., Bradley, C. A., Collingridge, G. L., & Kaang, B. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0143 · Cited by 70 · see citing works
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders
Torres, V. I., Vallejo, D., & Inestrosa, N. C. (2017) · Neural Plasticity · doi:10.1155/2017/8081758 · Cited by 68 · see citing works
Dougnon, G., & Matsui, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147550 · Cited by 71 · see citing works
The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome
Rio, C. A. C.-D., & Huntsman, M. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00245 · Cited by 67 · see citing works
Cortese, G. P., Olin, A., O’Riordan, K. J., Hullinger, R., & Bürger, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.004 · Cited by 71 · see citing works
Gonzalez, D., Tomasek, M. P., Hays, S. A., Sridhar, V., Ammanuel, S. G., Chang, C.-W., Pawlowski, K. S., Huber, K. M., & Gibson, J. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-19.2019 · Cited by 64 · see citing works
Self-citationExecutive Function in Fragile X Syndrome: A Systematic Review
Schmitt, L., Shaffer, R. C., Hessl, D. R., & Erickson, C. A. (2019) · Brain Sciences · doi:10.3390/brainsci9010015 · Cited by 65 · see citing works
Postsynaptic autism spectrum disorder genes and synaptic dysfunction
Bonsi, P., Jaco, A. D., Fasano, L., & Gubellini, P. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105564 · Cited by 67 · see citing works
Westmark, C. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.122 · Cited by 63 · see citing works
HOMER2, a Stereociliary Scaffolding Protein, Is Essential for Normal Hearing in Humans and Mice
Azaiez, H., Decker-Farrell, A. R., Booth, K. T. A., Simpson, A. C., Shearer, A. E., Huygen, P. L. M., Bu, F., Hildebrand, M. S., Ranum, P. T., Shibata, S. B., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005137 · Cited by 64 · see citing works
Mechanisms of endocannabinoid control of synaptic plasticity
Winters, B. L., & Vaughan, C. W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108736 · Cited by 63 · see citing works
Homer1 Mediates Acute Stress-Induced Cognitive Deficits in the Dorsal Hippocampus
Wagner, K. V., Hartmann, J., Mangold, K., Wang, X., Labermaier, C., Liebl, C., Wolf, M., Gassen, N. C., Holsboer, F., Rein, T., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4333-12.2013 · Cited by 61 · see citing works
Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5
Jong, Y.-J. I., Sergin, I., Purgert, C. A., & O’Malley, K. L. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094763 · Cited by 60 · see citing works
McCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 57 · see citing works
Self-citationImpaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology.
Ruegsegger, C., Stucki, D. M., Steiner, S., Angliker, N., Radecke, J., Keller, É., Zuber, B., Rüegg, M., & Saxena, S. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.033 · Cited by 45 · see citing works
de Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 57 · see citing works
Luo, P., Chen, T., Zhao, Y., Zhang, L., Yang, Y., Liu, W., Li, S., Rao, W., Dai, S., Yang, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.116 · Cited by 55 · see citing works
Abnormal mGluR-mediated synaptic plasticity and autism-like behaviours in Gprasp2 mutant mice
Edfawy, M., Guedes, J. R., Pereira, M. I., Laranjo, M., de Carvalho, M. L., Gao, X., Ferreira, P. A., Caldeira, G. L., Franco, L. O., Wang, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09382-9 · Cited by 56 · see citing works
Shen, Y., & Niswender, C. M. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.022 · Cited by 53 · see citing works
Homeostatic Intrinsic Plasticity Is Functionally Altered in Fmr1 KO Cortical Neurons
Bülow, P., Murphy, T. J., Bassell, G. J., & Wenner, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.035 · Cited by 53 · see citing works
Regulation of RNA granules by FMRP and implications for neurological diseases
Lai, A., Valdez‐Sinon, A. N., & Bassell, G. J. (2020) · Traffic · doi:10.1111/tra.12733 · Cited by 53 · see citing works
Yu, F., Zhong, P., Liu, X., Sun, D., Gao, H., & Liu, Q.-S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.29 · Cited by 52 · see citing works
Guo, W., Ceolin, L., Collins, K. A., Perroy, J., & Huber, K. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.013 · Cited by 51 · see citing works
Self-citationGuo, W., Molinaro, G., Collins, K. A., Hays, S. A., Paylor, R. E., Worley, P. F., Szumlinski, K. K., & Huber, K. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2921-15.2016 · Cited by 51 · see citing works
Self-citationEisinger, K. R. T., Gross, K. S., Head, B. P., & Mermelstein, P. G. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.03.001 · Cited by 50 · see citing works
Scaffolding protein Homer1a protects against NMDA-induced neuronal injury
Wang, Y., Rao, W., Zhang, C., Zhang, C., Liu, M.-D., Han, F., Yao, L.-B., Han, H., Luo, P., Su, N., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.216 · Cited by 50 · see citing works
Fragile X syndrome: From targets to treatments
Wijetunge, L. S., Chattarji, S., Wyllie, D. J. A., & Kind, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.028 · Cited by 49 · see citing works
Homer1 Scaffold Proteins Govern Ca2+ Dynamics in Normal and Reactive Astrocytes
Buscemi, L., Ginet, V., Lopatář, J., Montana, V., Pucci, L., Spagnuolo, P., Zehnder, T., Grubišić, V., Truttman, A., Sala, C., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw078 · Cited by 47 · see citing works
From FMRP Function to Potential Therapies for Fragile X Syndrome
Sethna, F., Moon, C., & Wang, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1229-3 · Cited by 47 · see citing works
The role of neurotrophic factors in novel, rapid psychiatric treatments
Kim, J., He, M. J., Widmann, A. K., & Lee, F. S. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01717-x · Cited by 46 · see citing works
Sengmany, K., & Gregory, K. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13281 · Cited by 47 · see citing works
Bryostatin-1 Restores Hippocampal Synapses and Spatial Learning and Memory in Adult Fragile X Mice
Sun, M., Hongpaisan, J., Lim, C. S., & Alkon, D. L. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214098 · Cited by 44 · see citing works
Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD
Zantomio, D., Chana, G., Laskaris, L., Testa, R., Everall, I., Pantelis, C., & Skafidas, E. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.006 · Cited by 45 · see citing works
Banerjee, A., Luong, J. A., Ho, A., Saib, A., & Ploski, J. E. (2016) · Molecular Autism · doi:10.1186/s13229-016-0077-9 · Cited by 43 · see citing works
Modulation of behavior by scaffolding proteins of the post-synaptic density
Gao, C., Tronson, N. C., & Radulović, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.014 · Cited by 41 · see citing works
mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence
Stoppel, D. C., McCamphill, P. K., Senter, R. K., Heynen, A. J., & Bear, M. F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.718953 · Cited by 41 · see citing works
Moutin, E., Sakkaki, S., Compan, V., Bouquier, N., Giona, F., Areias, J., Goyet, E., Hemonnot-Girard, A.-L., Seube, V., Glasson, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01230-x · Cited by 41 · see citing works
Hippocampal Regulation of Postsynaptic Density Homer1 by Associative Learning
Clifton, N. E., Cameron, D., Trent, S., Sykes, L., Thomas, K. L., & Hall, J. (2017) · Neural Plasticity · doi:10.1155/2017/5959182 · Cited by 39 · see citing works
- Authors
- Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Huber, Kimberly M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2012-01-22
- Volume
- 15
- Issue
- 3
- Pages
- 431-440
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC3288402
- OpenAlex
- W2134906491
- Cited by
- 251
- References
- 50
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 13 · 2021: 16 · 2020: 20 · 2019: 18 · 2018: 17 · 2017: 23 · 2016: 27 · 2015: 21 · 2014: 24 · 2013: 25 · 2012: 16
- FWCI
- 16.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Autism Speaks (AS2086)
- National Institute of General Medical Sciences (GM008203, T32GM008203)
- National Institute of Neurological Disorders and Stroke (R01NS045711, NS045711)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD052731, HD-052731, HD056370, R01HD056370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- fragile X syndrome, mGluR5, Homer1a, Fmr1 knockout mice, intellectual disability, autism spectrum disorder, synaptic depression, translational regulation, FMRP, cognitive impairment
- MeSH terms
- Homer Scaffolding Proteins, Analysis of Variance, Animals, Carrier Proteins, Cycloheximide, Disease Models, Animal, Electric Stimulation, Exploratory Behavior, Fragile X Syndrome, Gene Expression Regulation, Hippocampus, Methoxyhydroxyphenylglycol, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Nerve Net, Peptides, Physics, Protein Synthesis Inhibitors, Serine, Signal Transduction, Long-Term Potentiation, Receptors, Metabotropic Glutamate, Patch-Clamp Techniques, Rats, Long-Evans, Immunoprecipitation, Mice, Rats, Fragile X Messenger Ribonucleoprotein 1, TOR Serine-Threonine Kinases, Receptor, Metabotropic Glutamate 5, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review